Transcriptome Profiling and Endometrial Receptivity

Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 18, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how certain biochemical markers in the body relate to the best time for a woman to become pregnant, known as the "window of implantation" (WOI). Researchers will collect blood samples and perform a small procedure called an endometrial biopsy, where a tiny sample of the lining of the uterus is taken, at specific times during a woman’s cycle to gather important information.

To participate, women aged 20 to 40 years old may be eligible, but those with certain uterine issues, such as fibroids, or other specific conditions will not be able to join. If you choose to participate, you can expect to provide blood samples and undergo the biopsy at scheduled visits. This study is currently looking for participants, so if you meet the age criteria and are interested in contributing to this important research, you may want to learn more about it!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age 20-40 years.
• Exclusion Criteria:
• • Uncorrected uterine anomalies, such as septate or bicornuate uterus, fibroids (submucous/intramural).
• • Intrauterine adhesions.
• • Adenomyosis.